Skip to main content
An official website of the United States government
Email

Contact the Division of Cancer Biology

Division of Cancer Biology
9609 Medical Center Drive MSC 9747/9748
Bethesda, MD 20892

Follow DCB on Twitter

Office of the Director

The Director’s Office oversees the activities of the branches as well as special initiatives and Programs funded by the Division. The Office also fosters emerging topics in basic cancer biology, such as cancer systems biology, physical sciences in oncology, and the tumor microenvironment, in order to facilitate the development of the field.

More information on research supported by the Office of the Director is available in the Research section.

Phone: (240) 276-6180
Fax: (240) 276-7861

Name & Position Email Areas of Expertise

Daniel Gallahan, Ph.D.

Director

[email protected] Cancer biology

Shannon Hughes, Ph.D.

Deputy Director

[email protected] Cancer metastasis and systems biology

Lisa Witzler, Ph.D.

Chief of Staff

[email protected] DCB processes and policies

Ruth Bonnerjee

Staff Assistant

[email protected] DCB event processes and policies

Jason Bunting

Information Technology (IT) Specialist

[email protected] IT and technology platforms

Yvette Butler

Program Specialist

[email protected] DCB travel processes and policies

Tamika Carney

Program Analyst

[email protected] Point of contact for the Director of DCB

Janice Embry

Program Analyst

[email protected] DCB administrative processes and policies

Riante Jones

Communications Specialist

[email protected] Health communication

Soumya Korrapati, Ph.D.

Scientific Policy Analyst

[email protected] NIH Data Management and Sharing Policy

Claire McCarthy, Ph.D.

Communications Manager

[email protected] DCB communications

Michelle Turner

Program Analyst

[email protected] DCB portfolio and data analysis

Matthew Whitehead

Office Automation Technician

[email protected] Automation systems

Cancer Cell Biology Branch

CCBB supports and directs research that defines the biological basis for the differences between normal cells and cancer cells, with a major emphasis on studies that reveal processes and molecular targets where there is potential for therapeutic or preventive intervention.

More information on research supported by this branch is available in the Research section.

Phone: (240) 276-6230
Fax: (240) 276-7865

Name & Position Email Areas of Expertise

Rihab Yassin, Ph.D.

Chief

[email protected] Gastroesophageal cancers biology, tumor-initiating cells, stem cell biology, and plasticity

Cheryl Cero, Ph.D.

Program Director

[email protected] Cell cycle regulations, senescence, and R03 grants in cancer cell biology

Sharmistha Ghosh-Janjigian, Ph.D.

Program Director

[email protected] Early lesion biology, as well as oncogenes and their mechanisms

Ruibai Luo, Ph.D.

Program Director

[email protected] Post-translational modifications, circadian biology, and R15 and R50 grants in cancer cell biology

Stefan Maas, Ph.D.

Program Director

[email protected] RNA biology and RNA regulation of cancer processes, tumor suppressors and associated mechanisms, and the regulation of translation

Konstantin Salnikow, Ph.D

Program Director

[email protected] Cell death and survival pathways, cell stress in cancer, and the role of sex in cancer biology

Kristine Willis, Ph.D.

Program Director

[email protected] Cancer cell metabolism and energetics, intersection of diet with cancer metabolism, mitochondria, and experimental models

Wanping Xu, Ph.D.

Program Director

[email protected] Cancer cachexia pathways and models, cancer signaling pathways, and cellular chaperones

Cancer Immunology, Hematology, and Etiology Branch

CIHEB includes the Immunology and Hematology Section and the Cancer Etiology Section.

The Immunology and Hematology Section supports studies on the basic mechanisms of anti-tumor immune responses and hematologic malignancies.

The Cancer Etiology Section supports two broad categories of studies on possible etiological factors or co-factors in cancer: biological agents (primarily viruses and bacteria) and host predisposing states including obesity, diet, and aging.

More information on research supported by this branch is available in the Research section.

Phone: (240) 276-6200
Fax: (240) 276-7867

Name & Position Email Areas of Expertise

Kevin Howcroft, Ph.D.

Chief

[email protected] Cancer immunology, multiple myeloma, extracellular vesicles, and retrotransposons

Phil Daschner

Program Director

[email protected] Cancer etiology, biological carcinogenesis, microbiome, and the role of diet/nutrition/obesity in cancer

Yvonne Duglas-Tabor

Program Associate Director

[email protected] R13 and R50 grants related to cancer immunology and cancer health disparities

Chamelli Jhappan, Ph.D

Program Director

[email protected] Oncogenic RNA viruses, hematopoietic malignancies, multidrug resistance in cancer, and the nervous system regulation of cancer

Margaret Klauzinska, Ph.D.

Program Director

[email protected] Hematopoiesis, myeloid malignancies, bone marrow niche, and epitranscriptomics

Lillian Kuo, Ph.D.

Program Director

[email protected] Immunology and virology, microscopy for cancer, vesicle biology, and molecular biology related to antitumor immunity

Yin Liu, Ph.D.

Program Director

[email protected] Immunity/autoimmunity, inflammation, lymphocyte migration, and T cell receptor signaling

Susan McCarthy, Ph.D.

Volunteer

[email protected] T cells, immunosuppression, immunotherapy, and immunotherapy-related adverse events

Elizabeth Read-Connole, Ph.D.

Head - Cancer Etiology Section

[email protected] Cancer etiology, oncogenic viruses, and biology related to HIV/AIDS and cancer

Monica Zamisch, Ph.D.

Program Director

[email protected] Cancer immunology, molecular biology, vaccine development, and systems biology

Zulekha Sayyed, M.S.H.S.

Program Analyst

[email protected]  Medical technology, immunology, and biotechnology

DNA and Chromosome Aberrations Branch

DCAB supports basic cancer research focused on making clear the genetic and epigenetic mechanisms of tumorigenesis and mechanisms of chemical and physical carcinogenesis.

More information on research supported by this branch is available in the Research section.

Phone: (240) 276-6250
Fax: (240) 276-7865

Name & Position Email Areas of Expertise

Ian Fingerman, Ph.D.

Chief

[email protected] Cancer genomics, mechanisms of cancer susceptibility, genetic heterogeneity, and non-coding RNAs

Ron Johnson, Ph.D.

Program Director

[email protected] Chemical and tobacco carcinogenesis, replication stress, DNA damage signaling, and transcriptional regulation by ER and p53

Paul Okano, Ph.D

Program Director

[email protected] Epigenetic modifications, chemical and UV mutagenesis, DNA repair, and DNA polymerases

Anu Sharman, Ph.D.

Program Director

[email protected] Genomic/epigenomic alterations related to cancer health disparities, genetic models for cancer disparities, and R03, R15, and R50 grants related to DNA and chromosome aberrations

Michael Weinreich, Ph.D.

Program Director

[email protected] DNA replication, replication stress, cell cycle, and DNA damage checkpoints

Keren Witkin, Ph.D.

Program Director

[email protected] Genome instability and chromosomal rearrangements, double strand break repair pathways, telomere maintenance, and fusion oncoproteins

Biophysics, Bioengineering, and Computational Sciences Branch

BBCSB supports studies in three areas: technology development and molecular applications; biophysical biology; and computational/mathematical methods and bioinformatics development. The branch also supports integrated and systems biology approaches to cancer biology.

More information on research supported by this branch is available in the Research section.

Phone: (240) 276-6210
Fax: (240) 276-7863

Name & Position Email Areas of Expertise

Jennifer Couch, Ph.D.

Chief

[email protected] Artificial intelligence, technology development, citizen science, and structural biology

Anowarul Amin, Ph.D.

Program Director

[email protected] Biophysics, structure-function mechanisms, proteomics, and cellular imaging

Steven Becker, Ph.D.

Program Director

[email protected] Tissue engineering and 3D culture, regenerative medicine, cell characterization, and imaging technologies

Robin Brown

Program Associate Director

[email protected] SBMAB grant portfolio analysis and policies

Hannah Dueck, Ph.D.

Program Director

[email protected] Cancer systems biology, tumor heterogeneity, and single-cell biology

Eric Johnson Chavarria, Ph.D.

Program Director

[email protected] Cytoskeleton, protein structure, microfluidics and microfabrication, and single molecule techniques

Jerry Li, M.D., Ph.D.

Program Director

[email protected] Informatics, deep learning, protein structure modeling, and synthetic biology

David Miller, Ph.D.

Program Director

[email protected] Mathematical methods and analysis, computational modeling, software development, and data science

Tumor Biology and Microenvironment Branch

The Tumor Biology and Microenvironment Branch supports basic tumor/early lesion-microenvironment research across the different stages of tumorigenesis. The focus is on the mechanistic underpinnings of bidirectional tumor and/or early lesion interactions with its microenvironment as co-organizers dictating tumor initiation and/or indolence, progression and response to therapy.

More information on research supported by this branch is available in the Research section.

Phone: (240) 276-6220
Fax: (240) 276-7866

Name & Position Email Areas of Expertise

Jeffrey Hildesheim, Ph.D.

Chief

[email protected] Tumor-stroma co-organizer biology, mechanisms of therapy resistance, senescense, and stress signaling in tumors

Tapan Bera, Ph.D.

Program Director

[email protected] Treatment resistance, tumor cell plasticity and polarity, and molecular signaling in the tumor microenvironment

Christina George

Scientific Program Specialist

[email protected] R03, R13, and R50 grants related to the tumor microenvironment

Mihoko Kai, Ph.D.

Program Director

[email protected] Tumor heterogeneity, stem cell biology, non-coding RNAs in the microenvironment, and hormone signaling

Natalia Mercer, Ph.D.

Program Director 

[email protected]  Tumor stroma, tumor and microenvironment metabolism, protein modifications, and glycobiology

Elizabeth Woodhouse, Ph.D. 

Program Director 

[email protected] Extracellular vesicles, extracellular matrix and cell adhesion, angiogenesis, and cancer cell migration

Tumor Metastasis Branch

The Tumor Metastasis Branch plans, develops and directs the Division’s research program in tumor metastasis, focusing on mechanisms of metastasis and metastatic niches, circulating tumor cells, dormancy, and angiogenesis and vasculogenesis.

More information on research supported by this branch is available in the Research section.

Phone: (240) 276-6220
Fax: (240) 276-7866

Name & Position Email Areas of Expertise

Joanna Watson, Ph.D.

Chief

[email protected]  Circadian rhythms, cancer cachexia, circulating tumor cell biology, and mechanisms of metastasis

Grace Ault, Ph.D.

Program Director

[email protected] Cell invasion and migration, epithelial-mesenchymal transition, metabolic adaptation to the microenvironment, and growth factor signaling

Justin Benavidez, Ph.D.

Program Director

[email protected] Biological sciences, developmental biology, and cancer metastasis

Brunilde Gril, Ph.D. 

Program Director

[email protected] Brain metastases, blood-brain/tumor barrier, experimental therapies for metastasis, and receptor tyrosine kinase signaling

Christine Nadeau, Ph.D. 

Program Director

[email protected] Mammalian models of cancer, Notch signaling, breast cancer, and systemic immunity

Elizabeth Snyderwine, Ph.D. 

Program Director

[email protected] Xenobiotic and cellular metabolism, metastasis, aging biology, and the bone microenvironment

Fanta Whiting

Program Associate Director 

[email protected] R03, R15, and R50 grants related to cancer metastasis

Office of Cancer Genomics

The Office of Cancer Genomics supports the development and application of genomic science to improve cancer diagnosis, treatments, and outcomes for patients by bringing data and resources to the research community, uncovering and investigating the somatic, acquired changes that drive cancer, and identifying targets and strategies for precision medicine.

Administrative Resource Center

The Administrative Resource Center (ARC) of DCB and the NCI Division of Extramural Activities (DEA) is responsible for facilitating administrative processes involved in conducting the research activities and functions of DCB research areas.

Name & Position Email Areas of Expertise

Bridgette Tobiassen

Division ARC Manager

[email protected] NCI administrative and management policies and processes

Eric Graves

Division ARC Deputy Director

[email protected] DCB and DEA administrative and management policies and processes

Kelly Dyott

Administrative Officer 

[email protected] NCI travel policies and procurement processes

Kevin Greene 

Administrative Officer

[email protected] NCI financial policies/grants and DCB budget processes

Linda Stephens 

Administrative Officer

[email protected]  NCI Human Resources policies and processes

Paige Walker 

Administrative Technician

[email protected] DCB administrative and travel policies

Additional DCB/DEA ARC staff include the following DEA Administrative Officers: Rhudel Stevens (Lead Administrative Officer), Jamie Brewer, Katelyn Beahm, and Paul Fatula.

  • Updated:
Email